Collaborative Project on Potential Serum Markers for Malignant Melanoma, Metastatic Breast, Advanced Lung Pancreatic Carcinoma and Colorectal Cancer
OBJECTIVES:
Primary
- To assess which potential peptide and protein markers produced by human melanoma, lung,
breast, pancreatic, and colorectal cell lines may be detectable in serum of patients
from these five disease groups.
Secondary
- To conduct further extensive investigation with respect to identification of the
protein/peptide involved, determination of specificity for each cancer, and development
of more sensitive assays to look for such markers in a wider population of patients,
including those undergoing therapy.
OUTLINE: This is a multicenter study.
Blood samples are collected before surgical intervention or treatment to assess peptide and
protein markers.
Observational
Time Perspective: Prospective
Detection of peptide and protein markers in serum
Ongoing
No
Martin Clynes
Principal Investigator
National Institute for Cellular Biotechnology at Dublin City University
Ireland: Irish Medicines Board
CDR0000644159
NCT00974610
August 2008
Name | Location |
---|